AAL

Illumina Stock Rises After Sale of Grail

ILMN has been rallying up the charts the past month

Deputy Editor
Dec 18, 2023 at 11:04 AM
facebook X logo linkedin


After over two years of antitrust battles, Illumina Inc (NASDAQ:ILMN) will sell its cancer diagnostic test maker Grail through a third-party sale of capital markets transaction by the second quarter next year. The company spun off Grail in 2016 and retained a 12% stake, reacquiring Grail in 2021 despite competition concerns from the U.S. government. 

Illumina has pared its greater premarket gains, now up 1.3% at $128.77. The stock is fresh off four-straight weekly wins, though still down 36.4% since the start of the year, with newfound support at its 80-day moving average -- a trendline that provided strict pressure in the spring. 

When speculating on ILMN's next move, options look like a reasonable way to go. The stock's Schaeffer's Volatility Index (SVI) of 51% ranks in the 28th percentile of its annual range, meaning options traders are pricing in low volatility expectations at the moment. The stock has tended to outperform these expectations as well, per its Schaeffer's Volatility Scorecard (SVS) of 87 out of 100. 

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.